InsiderTrades

Form 4 for NVCR NovoCure Ltd

Accepted 2023-11-02 00:00:00 ET · period of report 2023-10-31 · accession 0001562180-23-007502 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-11-02 2023-10-31+ NVCR Cordova Ashley CFO M - OptEx $9.60 +18.0K 109.7K +20% +$172.5K
DM 2023-11-02 2023-10-31+ NVCR Cordova Ashley CFO M - OptEx $0.00 -18.0K 175 -99% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2023-10-31 M A 7,561 $11.46 107,211 D — —
2 Common Ordinary Shares 2023-11-02 M A 175 $11.46 117,618 D — —
3 Common Ordinary Shares 2023-10-31 M A 7,752 $7.15 117,443 D — —
4 Common Ordinary Shares 2023-10-31 M A 2,480 $11.44 109,691 D — —
5 Derivative Stock Option (Right to Buy) 2023-10-31 M D 2,480 $0.00 0 D $11.44 · 2020-07-27 to 2026-07-27 2,480 Ordinary Shares
6 Derivative Stock Option (Right to Buy) 2023-11-02 M D 175 $0.00 0 D $11.46 · — to 2026-02-24 175 Ordinary Shares (F1) Vests 2,686 share(s) on 24-Feb-2019, 6,250 share(s) on 24-Feb-2020
7 Derivative Stock Option (Right to Buy) 2023-10-31 M D 7,752 $0.00 0 D $7.15 · — to 2027-02-21 7,752 Ordinary Shares (F2) Vests 2 share(s) on 22-Feb-2018, 9,750 share(s) on 22-Feb-2021
8 Derivative Stock Option (Right to Buy) 2023-10-31 M D 7,561 $0.00 175 D $11.46 · — to 2026-02-24 7,561 Ordinary Shares (F1) Vests 2,686 share(s) on 24-Feb-2019, 6,250 share(s) on 24-Feb-2020